Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol (Baltimore, Md : 1950). 2014;192(12):5459–68.
Article
CAS
Google Scholar
Hagberg N, Ronnblom L. Systemic lupus erythematosus--a disease with a dysregulated type I interferon system. Scand J Immunol. 2015;82(3):199–207.
Article
CAS
PubMed
Google Scholar
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003;100(5):2610–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bengtsson AA, Ronnblom L. Role of interferons in SLE. Best Pract Res Clin Rheumatol. 2017;31(3):415–28.
Article
PubMed
Google Scholar
Ronnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med. 2019;6(1):e000270.
Article
PubMed
PubMed Central
Google Scholar
Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, et al. IFN-lambda1 with Th17 axis cytokines and IFN-alpha define different subsets in systemic lupus erythematosus (SLE). Arthritis Res Ther. 2017;19(1):139.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4(1):69–77.
Article
CAS
PubMed
Google Scholar
Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathogens. 2008;4(3):e1000017. https://doi.org/10.1371/journal.ppat.1000017.PMID:18369468).
Lin FC, Young HA. Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 2014;25(4):369–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lazear HM, Nice TJ, Diamond MS. Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity. 2015;43(1):15–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol. 2007;81(14):7749–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hertzog P, Forster S, Samarajiwa S. Systems biology of interferon responses. J Interf Cytokine Res. 2011;31(1):5–11.
Article
CAS
Google Scholar
Andreakos E, Zanoni I, Galani IE. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Curr Opin Immunol. 2018;56:67–75.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kotenko SV, Rivera A, Parker D, Durbin JE. Type III IFNs: beyond antiviral protection. Semin Immunol. 2019;43:101303.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, et al. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol (Baltimore, Md : 1950). 2012;189(6):2735–45.
Article
CAS
Google Scholar
Rönnblom L, Alm GV. The natural interferon-alpha producing cells in systemic lupus erythematosus. Hum Immunol. 2002;63(12):1181–93.
Article
PubMed
Google Scholar
Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood. 2006;108(12):3851–8.
Article
CAS
PubMed
Google Scholar
Eloranta ML, Lovgren T, Finke D, Mathsson L, Ronnelid J, Kastner B, et al. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 2009;60(8):2418–27.
Article
CAS
PubMed
Google Scholar
Hagberg N, Berggren O, Leonard D, Weber G, Bryceson YT, Alm GV, et al. IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1. J Immunol. 2011;186(9):5085–94.
Article
CAS
PubMed
Google Scholar
Berggren O, Hagberg N, Weber G, Alm GV, Ronnblom L, Eloranta ML. B lymphocytes enhance interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum. 2012;64(10):3409–19.
Article
CAS
PubMed
Google Scholar
Leonard D, Eloranta ML, Hagberg N, Berggren O, Tandre K, Alm G, et al. Activated T cells enhance interferon-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes. Ann Rheum Dis. 2016;75(9):1728–34.
Article
CAS
PubMed
Google Scholar
Lovgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Ronnblom L. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum. 2006;54(6):1917–27.
Article
PubMed
CAS
Google Scholar
Shafaie S, Hutter V, Brown MB, Cook MT, Chau DYS. Influence of surface geometry on the culture of human cell lines: a comparative study using flat, round-bottom and v-shaped 96 well plates. PLoS One. 2017;12(10):e0186799.
Article
PubMed
PubMed Central
CAS
Google Scholar
Weber G, Trowitzsch S, Kastner B, Luhrmann R, Wahl MC. Functional organization of the Sm core in the crystal structure of human U1 snRNP. EMBO J. 2010;29(24):4172–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bach M, Krol A, Luhrmann R. Structure-probing of U1 snRNPs gradually depleted of the U1-specific proteins A, C and 70k. Evidence that A interacts differentially with developmentally regulated mouse U1 snRNA variants. Nucleic Acids Res. 1990;18(3):449–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kastner B, Bach M, Luhrmann R. Electron microscopy of small nuclear ribonucleoprotein (snRNP) particles U2 and U5: evidence for a common structure-determining principle in the major U snRNP family. Proc Natl Acad Sci U S A. 1990;87(5):1710–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kelly PN, Romero DL, Yang Y, Shaffer AL 3rd, Chaudhary D, Robinson S, et al. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. J Exp Med. 2015;212(13):2189–201.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hjorton K, Hagberg N, Israelsson E, Jinton L, Berggren O, Sandling JK, et al. Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor. Arthritis Res Ther. 2018;20(1):238.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J Autoimmun. 1998;11(5):465–70.
Article
CAS
PubMed
Google Scholar
Khan S, Kaihara KA. Single-cell RNA-sequencing of peripheral blood mononuclear cells with ddSEQ. Methods Mol Biol. 1979;2019:155–76.
Google Scholar
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.
Article
CAS
PubMed
Google Scholar
Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.
PubMed
Google Scholar
Fitzgerald-Bocarsly P. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques. 2002;Suppl:16–20, 2, 4–9.
Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50(6):1861–72.
Article
PubMed
CAS
Google Scholar
Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus. 2000;9(9):664–71.
Article
CAS
PubMed
Google Scholar
Fiehn C, Wermann M, Pezzutto A, Hufner M, Heilig B. Plasma GM-CSF concentrations in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy. Z Rheumatol. 1992;51(3):121–6.
CAS
PubMed
Google Scholar
Willeke P, Schluter B, Schotte H, Erren M, Mickholz E, Domschke W, et al. Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption. Lupus. 2004;13(4):257–62.
Article
CAS
PubMed
Google Scholar
Tang Y, Tao H, Gong Y, Chen F, Li C, Yang X. Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients. J Interf Cytokine Res. 2019;39(7):410–5.
Article
CAS
Google Scholar
Iwano M, Dohi K, Hirata E, Kurumatani N, Horii Y, Shiiki H, et al. Urinary levels of IL-6 in patients with active lupus nephritis. Clin Nephrol. 1993;40(1):16–21.
CAS
PubMed
Google Scholar
Fishman P, Kamashta M, Ehrenfeld M, Vianna J, Hughes GR, Sredni D, et al. Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. Int Arch Allergy Immunol. 1993;100(3):215–8.
Article
CAS
PubMed
Google Scholar
Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, et al. IL-3 contributes to development of lupus nephritis in MRL/lpr mice. Kidney Int. 2015;88(5):1088–98.
Article
CAS
PubMed
Google Scholar
Oon S, Monaghan K, Ng M, Hoi A, Morand E, Vairo G, et al. A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus. Clin Transl Immunology. 2019;8(12):e01097.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zickert A, Oke V, Parodis I, Svenungsson E, Sundstrom Y, Gunnarsson I. Interferon (IFN)-lambda is a potential mediator in lupus nephritis. Lupus Sci Med. 2016;3(1):e000170.
Article
PubMed
PubMed Central
Google Scholar
Rose T, Dorner T. Drivers of the immunopathogenesis in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31(3):321–33.
Article
PubMed
Google Scholar
Berggren O, Alexsson A, Morris DL, Tandre K, Weber G, Vyse TJ, et al. IFN-alpha production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases. Hum Mol Genet. 2015;24(12):3571–81.
Article
CAS
PubMed
Google Scholar
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382(3):211–21.
Article
CAS
PubMed
Google Scholar
Zahn S, Rehkämper C, Kümmerer BM, Ferring-Schmidt S, Bieber T, Tüting T, et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. J Investigative Dermatol. 2011;131(1):133–40.
Article
CAS
Google Scholar
Wu et al.: Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity. Arthritis Res Ther. 2011;13:R8.
Chen JY, Wang CM, Chen TD, Jan Wu YJ, Lin JC, Lu LY, et al. Interferon-lambda3/4 genetic variants and interferon-lambda3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese. Arthritis Res Ther. 2018;20(1):193.
Article
PubMed
PubMed Central
CAS
Google Scholar
Amezcua-Guerra LM, Marquez-Velasco R, Chavez-Rueda AK, Castillo-Martinez D, Masso F, Paez A, et al. Type III interferons in systemic lupus erythematosus: association between interferon lambda3, disease activity, and anti-Ro/SSA antibodies. J Clin Rheumatol. 2017;23(7):368–75.
Article
PubMed
Google Scholar
Macal M, Jo Y, Dallari S, Chang AY, Dai J, Swaminathan S, et al. Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection. Immunity. 2018;48(4):730–44 e5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 2001;10(7):484–90.
Article
CAS
PubMed
Google Scholar